DR. Amanda Lynn Profit, MD is a molecular genetic pathology pathology in Dallas, TX with 18 years of experience. The provider is a molecular genetic pathologist is expert in the principles, theory and technologies of molecular biology and molecular genetics. This expertise is used to make or confirm diagnoses of Mendelian genetic disorders, disorders of human development, infectious diseases and malignancies, and to assess the natural history of those disorders. A molecular genetic pathologist provides information about gene structure, function and alteration and applies laboratory techniques for diagnosis, treatment and prognosis for individuals with related disorders. DR. Amanda Lynn Profit, MD NPI is 1962729194. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT HOUSTON
Graduation Year:2006
The provider's business location address is:
7777 FOREST LN STE A-200
DALLAS, TX
ZIP 75230-571
Phone: (972) 566-7283
The NPI 1962729194 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
- Pathology examination of tissue using a microscope, moderately high complexity (HCPCS:88307)
- Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
- Special stained specimen slides to examine tissue (HCPCS:88341)
- Tissue or cell analysis by immunologic technique (HCPCS:88342)
The enumeration date for this NPI number is 4/28/2010 and was last updated on 3/25/2020.